Alzheimers IV Treatments Alzheimer's IV treatment is designed to support individuals with early-stage Alzheimer's, mild cognitive impairment, or those at risk of neurodegenerative conditions
100%
Elevated levels of homocysteine in the blood have been shown to correlate with cardiovascular dysfunction
Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Brmann J et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinsons disease and age-matched controls
Several studies have suggested a potential link between low glutathione levels and chronic diseases such as diabetes, Alzheimers disease, and Parkinsons disease
This supports the position of mtDNA content as a potential predictor of immune recovery success